Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18758641)

  • 1. Bcl-2 expression in Hodgkin's lymphoma progression.
    Flangea C; Potencz E; Mihăescu R; Gîju S; Anghel A
    Rom J Morphol Embryol; 2008; 49(3):357-63. PubMed ID: 18758641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
    Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
    Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
    Macák J; Bertová M
    Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
    Qi ZL; Zhao T; Zhou XH; Zhang JH; Han XQ; Zhu MG
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
    van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
    Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
    Chen XQ; Wang WL; Huang GS
    Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
    Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
    Acta Med Croatica; 2004; 58(3):183-6. PubMed ID: 15503680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
    Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
    Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
    Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
    Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D; Roy SK
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hodgkin's disease in Zaire: histological and anatomo-clinical profile].
    Mubikayi L; Kalengayi MM
    IARC Sci Publ; 1984; (63):675-85. PubMed ID: 6536628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
    Lee MY; Tan TD; Feng AC
    Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
    Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
    Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
    Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
    Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.
    Zyada MM; Grawish ME; Elsabaa HM
    Ann Diagn Pathol; 2009 Oct; 13(5):313-21. PubMed ID: 19751908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dural infiltration of metastatic Hodgkin's lymphoma.
    Elwell VA; Carney L; Johns P; Grieve JP
    Br J Neurosurg; 2008 Jun; 22(3):439-40. PubMed ID: 18568736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case.
    Seliem RM; Chikwava K; Swerdlow SH; Young RH; Ferry JA
    Int J Surg Pathol; 2007 Apr; 15(2):207-12. PubMed ID: 17478785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.